On the other hand, the introduction of side-chain chiral substitutions with non-natural D-amino acid replacements on the 1286LeuLysPro1288 motif from the MSP1-C-terminal peptide B6, associated with critical residues of binding to red blood cells [19], stimulates the production of antibodies that favor protection against the experimental challenge, as can be seen in B6An1 (-Y-dL1546-K-) and B6An2 (-L-dK1547-P-), efficiently controlling the parasitemia levels in immunized animals. Here, ATAD1 is linked to parasitic infectious disease.